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Antemortem detection of PrPCWD in preclinical, ranch-raised Rocky
Mountain elk (Cervus elaphus nelsoni) by biopsy of the rectal mucosa
Terry R. Spraker, Kurt C. VerCauteren, Thomas Gidlewski, David A. Schneider, Randy Munger,
Aru Balachandran, Katherine I. O’Rourke1
Abstract. Antemortem biopsy of the rectal mucosa was evaluated as a method for the preclinical diagnosis
of chronic wasting disease (CWD) in a herd of ranch-raised Rocky Mountain elk (Cervus elaphus nelsoni)
quarantined because of exposure to CWD. Biopsy samples were obtained from 41 elk during the winter of
2005–2006 and from 26 elk from that herd still alive and available for testing during the winter of 2006–2007.
Samples were examined for PrPCWD, the protein marker for CWD infection, by immunohistochemistry.
PrPCWD was detected in follicles of the rectoanal mucosa-associated lymphoid tissue in biopsy samples from 1
elk with clinical signs of chronic wasting disease and 5 clinically normal elk. The diagnosis was confirmed in all
6 animals by postmortem analysis of brain and peripheral lymph nodes. PrPCWD was also observed in the
submucosal plexus and myenteric plexus of the enteric nervous system, and in close association with
nonmyelinated mucosal and submucosal nerve fibers. In antemortem rectal biopsy samples from positive
animals, immunostaining was consistently observed in approximately 60% of the mucosa-associated lymphoid
tissue follicles if 10 or more total follicles per biopsy were present for evaluation. Most antemortem biopsy
samples obtained from elk younger than 6.5 years contained at least 10 follicles per rectal mucosal biopsy.
These findings support the analysis of antemortem biopsy of the rectal mucosa samples as part of an
integrated strategy to manage chronic wasting disease in Rocky Mountain elk.
Key words: Antemortem diagnosis; chronic wasting disease; elk; transmissible spongiform encephalopathy.
Introduction
Chronic wasting disease (CWD), a transmissible
spongiform encephalopathy, has been reported in
captive and free-ranging mule deer (Odocoileus
hemionus), white-tailed deer (Odocoileus virginianus),
Rocky Mountain elk (Cervus elaphus nelsoni), and
moose (Alces alces shirasi).3,22,26,27 Chronic wasting
disease has been a devastating disease in the captive
elk industry. An estimated 12,000–14,000 captive elk
have been killed in the last 8 years in attempts to
control CWD. Several thousand free-ranging mule
deer, white-tailed deer, and elk also have been killed
through liberalized hunting and targeted sharp-
shooting in attempts to reduce the disease prevalence
in the wild. Since captive cervids cannot be ruled out
as a source of CWD infection for free-ranging cervids,
eradication of CWD in captive herds is likely to be
critical in controlling the spread of this disease. An
accurate antemortem diagnostic test to identify
preclinical CWD-infected elk is essential to the
success of management strategies aiming to control
and eradicate CWD.
An abnormal isoform (PrPCWD) of the host prion
protein is a reliable marker for CWD in white-tailed
deer,22 mule deer,23 and Rocky Mountain elk.20
PrPCWD and the corresponding abnormal prion
protein PrPSc in sheep accumulate in lymphoid tissues
during the prolonged preclinical stage of disease,
providing the basis for antemortem testing in these
species.21,25,28 Preclinical tests for scrapie in domestic
sheep include biopsy of lymphoid tissues from the
palatine tonsil,24 third eyelid,14 and rectal mucosa.5,6
Similar preclinical tests have been described for mule
deer using biopsy of the palatine tonsil and rectal
mucosa.25,28 An immunohistochemical study21 of
rectoanal mucosa–associated lymphoid tissue (RA-
MALT) collected postmortem from elk suggested
that antemortem diagnosis may be possible in cases
with preclinical disease. The present study assessed
the feasibility of obtaining suitable antemortem rectal
biopsies of RAMALT from a mixed-age herd of
Rocky Mountain elk with known exposure to CWD.
From the Colorado State University Diagnostic Laboratory,
College of Veterinary Medicine, Colorado State University, Fort
Collins, CO (Spraker); the National Wildlife Research Center,
Wildlife Services (VerCauteren) and Veterinary Services (Gid-
lewski, Munger), U.S. Department of Agriculture, Animal and
Plant Health Inspection Service, Fort Collins, CO; Agricultural
Research Services, U.S. Department of Agriculture, Pullman, WA
(Schneider, O’Rourke); and the OIE and National Reference
Laboratory for Scrapie and CWD, Canadian Food Inspection
Agency, Nepean, ON, Canada (Balachandran).
1 Corresponding Author: Katherine O’Rourke, USDA, ARS
ADRU, 3003 ADBF, Pullman, WA 99164. katherine.o’rourke@
ars.usda.gov
J Vet Diagn Invest 21:15–24 (2009)
15
The study included consideration of prion protein
genotype in the study animals because a naturally
occurring polymorphism in the gene PRNP, encoding
the normal prion protein, is associated with relative
incubation time in experimentally infected elk.16 The
study also investigated the relationship of a positive
antemortem rectal biopsy with disease stage as
assessed by clinical signs and a previously described
brain immunohistochemical scoring system.20 Al-
though fewer RAMALT follicles were typically
present in biopsy samples obtained from Rocky
Mountain elk older than 5 years, the test was used
to identify live elk aged 3.5–6.5 years with late-stage
clinical, early clinical, and preclinical CWD. Ante-
mortem testing by biopsy of the rectal mucosa should
be a suitable component of an integrated CWD
management plan for captive elk.
Materials and methods
Samples
Biopsy of the rectal mucosa was performed in a herd of
ranch-raised Rocky Mountain elk located in an area of
north-central Colorado (the study ranch), where CWD is
enzootic in free-ranging elk and deer. The study ranch was
started in 2000 on 15 hectares of land with 21 elk (sources:
2 elk ranches in Colorado and an auction). Seven of these
elk were purchased from a herd that 4 months later was
depopulated because of a single confirmed case of CWD.
The study ranch was placed under quarantine and was
double fenced; however, the perimeter fence was occasion-
ally visited by free-ranging elk, especially during rutting
season. The first case of CWD on the study ranch was
diagnosed in 2002 in a 3-year-old bull that had been
purchased as a calf from the infected source ranch. As of
March 2008, 12 cases of CWD had been diagnosed on the
study ranch (Table 1).
In the first year of the study (October 2005–January
2006), antemortem rectal biopsies were obtained from each
elk (n 5 41) on the study ranch. Animals available for
testing included 1 bull elk with evidence of clinical disease,
1 cow with mild weight loss and some behavioral changes,
and 39 clinically normal elk (12 cows aged 3–14 years, 14
bulls aged 3–8 years, and 13 long yearlings aged 15–18
months, including 2 females and 11 males). Fifteen of these
elk were sampled 2 or 3 times over this 4-month period to
develop a preferred method for visualization of the tissue
and optimal sample size and location. There was no
evidence from examination of the animals on subsequent
testing that the repeat biopsy sampling induced inflamma-
tion lasting more than a few days, and complete healing of
the biopsy site occurred over 2–3 weeks, as evidenced by
analysis of the tissue at necropsy. Four elk were removed
following detection of PrPCWD in RAMALT samples, 9 elk
were euthanized for management reasons, and 1 elk was
not available for testing in the second year of the study. The
remaining 26 elk were tested using a single rectal biopsy
collected between September 2006 and February 2007. Two
elk with negative PrPCWD RAMALT samples in the first
year of the study had positive RAMALT findings in the
second year; these cases are described below. One
RAMALT-negative, clinically normal elk was culled for
management reasons at the end of this sampling period,
and 1 bull that had not been tested in either year of the
program died from a fall. Elk with positive immunolabeling
in biopsy samples and elk culled for management reasons
were euthanized with an overdose of pentobarbital sodium
and phenytoin sodium.a Brain, retropharyngeal lymph
node, palatine tonsil, and RAMALT were collected at the
time of necropsy from all elk in the study.
Antemortem biopsy of the rectal mucosa
Elk were restrained in a hydraulic squeeze chute and
positioned so that the rectum could be reached easily and
the danger of being kicked was minimized. To relax the
















P906 Bull MM ND ND May 2002 3 Yes 4
P902 Bull MM ND ND Apr 2003 4 Yes 4
ORL9 Bull MM ND ND Dec 2003 1.5 Yes 4
Y20 Cow LM ND ND May 2004 6 Yes 4
Y927 Bull MM ND ND Dec 2004 4.5 Yes 4
Y1671 Bull MM 82.5 4 Oct 2005 5 Yes 4
B1621 Cow MM 25.0 2 Oct 2005 5 No 4
OR4L1 Bull MM 66.7 4 Dec 2005 3.5 No 3
OR7L1 Bull MM 60.0 4 Feb 2006 3.5 No 3
OR6L1 Cow MM 58.3 4 Jan 2007 5.5 No 3
W60/A2 Bull MM ND ND Jan 2007 2.9 No 3
W4001 Bull MM 100.0 4 Feb 2007 6.5 No 4
* RAMALT 5 rectoanal mucosa-associated lymphoid tissue; ND 5 not done; Dx 5 diagnosed.
{ Intensity and distribution of immunohistochemistry immunolabeling as described previously.20
{ Percentage of follicles with immunohistochemistry immunolabeling as described previously.21
1 Elk with CWD detected by antemortem RAMALT testing include 1 clinical suspect and 5 clinically normal elk.
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rectal wall and enhance exposure of the rectal mucosa, a
gloved hand covered with large animal obstetrical lubri-
cating gel compounded with a topical anestheticb was
inserted into the rectum approximately 10 cm and held
stationary for 4–5 sec. The hand was then withdrawn. The
index and middle fingers of the gloved hand were then used
to vertically dilate the anus, thus exposing the lateral walls
for biopsy. A second person using sterile, stainless-steel,
curved blunt scissors (14 cm) and rat-toothed tissue forceps
obtained an approximately 1.0 3 1.5 cm biopsy sample of
the rectal mucosa starting at a distance approximately 1.0–
2.0 cm anterior to the mucocutaneous junction. A small
degree of bleeding occurred in some cases but was easily
controlled by applying local digital pressure. No other
adverse side effects were noted. Use of a head lamp by the
surgeon greatly facilitated the procedure. All instruments
were used once and then soaked for 1 hr in 50% household
bleach (3.0% sodium hypochlorite) before discarding.
Immunohistochemical immunolabeling technique
Medulla at the level of the obex (referred to as obex),
palatine tonsil, retropharyngeal lymph node, and rectal
mucosa were assayed for PrPCWD by immunohistochemistry
(IHC) as described previously.21 Briefly, samples were
routinely fixed in buffered formalin, processed, and
embedded in paraffin blocks. Antigen retrieval included
treatment with formic acid and hydrated autoclaving in
citrate buffer. Immunohistochemistry immunolabeling was
performed on an automated platform using anti–prion
protein monoclonal antibody F99/97.6.1, alkaline phos-
phatase detection, and hematoxylin counterstaining.c Pos-
itive control tissues (lymphoid tissue and obex) from
confirmed cases of CWD were included with each run of
19 test slides. Negative control tissues were collected from
elk with no known CWD exposure. PrPCWD in the brain
appeared as coarse, red, granular, or particulate deposits
surrounding neurons and scattered in the neuropil. No
deposits were observed in negative control brain. Lym-
phoid tissues were considered positive if follicles contained
coarse, bright red, granular material. Follicles with a pale
blue background and no coarse granular deposits were
considered negative. No deposits were observed in the
absence of primary antibody.
Disease stage determination
In addition to recording clinical signs and assessing the
obex for spongiform change as described previously,20 the
stage of hindbrain pathology was assessed by scoring the
obex (0–4) for the distribution and intensity of IHC
immunolabeling as described previously.20 Briefly, the obex
was scored 0 if no PrPCWD was detected in a single section.
The obex was scored 1 if PrPCWD deposits were restricted to
the lower half of the dorsal motor nucleus of the vagus
nerve (DMNV). PrPCWD deposits filling the entire DMNV
and the nucleus of the solitary tract with no immunolabel-
ing of adjacent nuclei were considered grade 2. Relatively
heavy immunolabeling of the DMNV and moderate
immunolabeling in surrounding nuclei (the caudal portion
of the nucleus of the spinal tract of the trigeminal nerve, the
ambiguus nucleus, the reticular formation, the hypoglossal
nucleus, the olivary nuclei, and the accessory cuneate
nucleus) was considered grade 3. Intense immunolabeling
of the DMNV and the surrounding nuclei was considered
grade 4. The total number of lymphoid follicles observed
and the number considered positive were recorded for a
single section made from each biopsy sample of rectal
mucosa. Samples in which fewer than 10% of the follicles
contained immunolabeling were considered RAMALT
intensity score 1; samples with immunolabeling of $10%
and ,30% were considered score 2, $30% and ,50% were
considered score 3, and samples with $50% of the follicles
containing PrPCWD were considered RAMALT intensity
score 4.
Genotype analysis
The open reading frame of the PRNP gene, encoding the
prion protein precursor, was sequenced as described
previously.20 The deduced amino acid sequence15 for codon
132 is shown as methionine homozygote (MM), leucine
homozygote (LL), or leucine/methionine heterozygote
(LM).
Statistical analysis
SAS/INSIGHT for Windowsd was used to explore and
analyze the observations made on antemortem rectal
biopsies. Graphs for presentation were produced using
the program Origine version 6.0.
Results
Study farm history
The study farm was established in 2000, and the
first case of CWD was diagnosed 2 years later.
Chronic wasting disease was diagnosed in 4 more elk
before this biopsy study was initiated. These 5 cases
included four 132MM homozygotes (3 purchased and
1 born on the ranch) and one 132LM purchased
heterozygote. The heterozygous animal was 6 years of
age at the time of death; age at death for the 132MM
homozygotes ranged from 1.5 to 4.5 years. These
cases are shown in Table 1. Of the 41 elk in the
current study, 27 were 132MM, 12 were 132LM, and
1 was 132LL. One elk with clinical signs suggestive of
CWD and 5 clinically normal elk were identified as
CWD suspects based on RAMALT testing; these
cases are described below. One 2.9-year-old 132MM
elk died from a fall and was diagnosed with CWD by
postmortem analysis; this animal had not been tested
by RAMALT sampling.
Antemortem testing and disease staging of elk
Case 1. Case 1 was a 5-year-old bull (Y167;
Table 1) with clinical signs consistent with late-stage
CWD. Clinical signs included those associated with
respiratory distress, weight loss, grinding of the teeth,
and excessive salivation. Antemortem biopsies of the
lymphoid tissues were collected from the nictitating
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membrane (Fig. 1A) and rectal mucosa (Fig. 1B); the
tissues had similar IHC immunolabeling patterns,
consistent with those reported for samples collected
from necropsy specimens.21 Because of the relative
ease of collecting rectal tissue biopsies, only
RAMALT was collected from the other elk in the
present study. The bull was euthanized. At necropsy,
gross lesions included emaciation, serous atrophy of
fat, and bronchopneumonia. Immunohistochemistry
immunolabeling in the obex was scored as 4.
Spongiform degeneration was evident within the
DMNV and surrounding nuclei, confirming the diag-
nosis of CWD. Immunohistochemistry immunolabel-
ing was observed in follicles of the palatine tonsil and
retropharyngeal lymph node, and also in 52 (82.5%)
of 63 RAMALT follicles.
Case 2. A 5-year-old cow (B162; Table 1)
displayed subtle signs suggestive of CWD, including
mild weight loss and behavioral changes, such as
seeking solitude and mild aggression. The behavioral
changes were noticed by the owners but could not be
confirmed by the attending author (T. R. S.). In the
absence of unequivocal signs, the cow was considered
to be in the preclinical phase of the disease for the
purposes of this study. Immunohistochemistry
immunolabeling was observed in 1 (25%) of 4
RAMALT follicles in an antemortem biopsy of the
rectal mucosa. At postmortem examination, the only
gross finding was the minimal presence of adipose
tissue. Examination of the rectum revealed a small
healing area where the antemortem biopsy had been
taken 10 days previously. Immunohistochemistry
immunolabeling of the obex was similar to the
distribution and intensity seen in case 1 and was
assigned a score of 4. Spongiform degeneration was
found in the DMNV and adjacent nuclei of the brain
stem. Immunohistochemistry immunolabeling was
observed in follicles of the palatine tonsil and
retropharyngeal lymph node, and in 23 (71.9%) of
32 RAMALT follicles.
Histopathological examination of the site of the
biopsy revealed a small area of the rectum character-
ized by loss of rectal crypt mucosa covered by a single
layer of rectal epithelial cells. A moderate degree of
fibroplasia was present in the bed of this defect. Only
a few neutrophils were observed in the healing region
of the rectal mucosa. The RAMALT follicles were
not found under the healing defect of rectal mucosa.
Case 3. Immunohistochemistry immunolabeling
was detected in 10 (66.7%) of 15 RAMALT follicles
from a biopsy of the rectal mucosa collected from a
clinically normal 4.5-year-old bull (OR4L; Table 1).
At postmortem examination, the bull was in good
body condition. Immunohistochemistry immuno-
labeling of the obex was scored a 3. Mild
spongiform degeneration was found in the DMNV
but not in the adjacent nuclei. Immunohistochemistry
immunolabeling was observed in follicles of the
palatine tonsil and retropharyngeal lymph node,
and in a total of 184 (68.4%) of 269 RAMALT
follicles as the sum of 3 sections collected from
different areas of the rectal tissue. Examination of the
rectum revealed no lesion where the biopsy had been
taken 3 weeks prior to euthanasia.
Case 4. Immunohistochemistry immunolabeling
was detected in 27 (60%) of 45 RAMALT follicles in
a biopsy sample of rectal mucosa from a clinically
normal 4.5-year-old bull (OR7L; Table 1). The
owners requested a second biopsy because of the
apparent health of this bull. Immunohistochemistry
immunolabeling in the second biopsy sample was
observed in 21 (55.3%) of 38 RAMALT follicles. The
bull was found to be in good body condition at
postmortem examination. Based on IHC
immunolabeling, the obex was scored 3. Mild
spongiform degeneration was found in the DMNV
but not in adjacent nuclei. Immunohistochemistry
immunolabeling was observed in follicles of the
palatine tonsil and retropharyngeal lymph node,
and in 29 (85.3%) of 34 RAMALT follicles.
Examination of the rectum revealed 2 small healing
areas where the biopsies had been taken 7 and 10 days
prior to euthanasia (Fig. 2A). These areas were
characterized by total loss of mucosa with a moderate
degree of fibroplasia within the submucosa. A
moderate number of neutrophils were present on the
surface and within the fibroplastic bed of the defect
(Fig. 2B).
Case 5. Cow OR6L (Table 1) was a large animal
with no apparent clinical signs when sampled at 5.5
years of age in November 2005 and when sampled
again at 6.5 years of age in January 2007.
Immunohistochemistry immunolabeling was not
observed in any of the 50 RAMALT follicles
examined in the November 2005 biopsy samples (1
sample with 20 follicles and 1 sample with 30 follicles),
but was observed 14 months later in 14 (58.3%) of 24
RAMALT follicles in the biopsy sample collected in
January 2007. A fourth biopsy was requested by the
owners because of the apparent health of the cow; IHC
immunolabeling was observed in 8 (53.3%) of 15
RAMALT follicles. At postmortem examination, this
cow was in excellent body condition. The obex was
scored a 3, based on the widespread but moderate
deposits of PrPCWD. Mild spongiform degeneration
was found in the DMNV but not in adjacent nuclei.
The palatine tonsil and retropharyngeal lymph node
contained PrPCWD deposits. Examination of the rectum
revealed 2 small healing defects where the biopsies had
been taken 7 and 14 days prior to euthanasia; these
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appeared histologically similar to those described
above.
Case 6. Immunohistochemistry immunolabeling
was observed in 3 (100%) of 3 RAMALT follicles in a
biopsy sample of rectal mucosa obtained from a
clinically normal 6.5-year-old bull (W400; Table 1) in
February 2007. This bull had been sampled in
January 2006, at which time IHC immunolabeling
was not observed in 10 RAMALT follicles examined.
The bull was not euthanized following the positive
biopsy sample; the animal died in July 2007. At
postmortem examination, this bull was emaciated.
Intense widespread deposits of PrPCWD were observed
in the obex (grade 4). Spongiform degeneration was
found in the DMNV and adjacent nuclei. In addition
to the rectal biopsy findings, IHC immunolabeling
was also observed in the palatine tonsil and
retropharyngeal lymph node. Postmortem examina-
tion of the rectum revealed no evidence of the
biopsy.
Elk with no detectable PrPCWD in RAMALT
samples. Immunohistochemistry immunolabeling
was not observed in RAMALT follicles obtained by
antemortem rectal biopsy from any of the other elk
Figure 2. A, gross photograph of the rectal mucosa of an elk. Note the dark line, the mucocutaneous junction (MCJ), at the
intersection of the rectal mucosa (top of photograph) and the epithelium of the rectum (bottom of photograph). Two defects are visible,
representing the 2 biopsy sites. The first is the location where a biopsy was taken 10 days prior to euthanasia (small arrow), and the larger
one was taken 7 days prior to euthanasia (large arrow). B, photomicrograph of the rectal mucosa of an elk 7 days following biopsy. Note
the absence of mucosa and the presence of fibroplasia of the submucosa and neutrophilic infiltration (Inf ) within the bed and on the
surface of the biopsy site. Note that the enterocytes are beginning to cover the surface of the area around the margins (E). Hematoxylin
and eosin immunolabeling. Bar 5 100 mm.
Figure 1. Photomicrograph of lymphoid follicles in the third eyelid of an elk with CWD. A, note the bright red chromogen
deposition filling one of the PrPCWD-positive lymphoid follicles (PF). Note 3 more follicles with minimal accumulation of red chromogen.
Immunohistochemical immunolabeling: streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar 5 200 mm. B,
note the bright red chromogen deposition in the PF. M 5 mucosa; SM 5 submucosa. Immunohistochemical immunolabeling:
streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar 5 200 mm.
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during the study period. Eleven elk with negative
RAMALT findings were culled to reduce the size of
the herd. These elk were found to be PrPCWD negative
in samples of obex, retropharyngeal lymph node, and
palatine tonsil; this group included nine 132MM and
two 132LM elk between the ages of 4.5 and 10.5
years. Twenty-four elk remained alive at the end of
the study period. The CWD status of these elk will
not be known until they are culled; thus, sensitivity
and specificity of antemortem biopsy of the rectal
mucosa for detection of PrPCWD cannot be determined
for this herd at this time.
Observations on factors affecting the number of RAMALT
follicles present for evaluation in a biopsy of rectal mucosa
Antemortem RAMALT evaluation. Rectal biopsies
were collected antemortem from 40 elk (25 bulls and
15 cows) with no unequivocal clinical signs suggestive
of CWD during the winter of 2005–2006. Bull elk had
a narrower age range of 1.5–8.5 years (median: 3.5
years) in comparison with the age range of the cow
elk (1.5–14.5 years; median: 6.0 years). Bull elk
represented 62.5% of the population examined at
this time. The frequencies of PRNP codon 132
genotypes (MM/LM/LL) within the bull elk
population were 19:6:0, and in the cow elk
population were 8:6:1. The single 132LL elk, a 14.5-
year-old cow, was the oldest animal examined.
Of the 5 preclinical RAMALT-positive elk cases
described above, PrPCWD had been detected in
antemortem rectal biopsy samples (Fig. 3, filled
circles) but not detected (open circles) in the initial
rectal biopsy samples collected 1 year earlier from 2 of
these animals, even though a similar or larger number
of follicles were present for evaluation in each biopsy
sample. A first approximation of the percent of
observed RAMALT follicles per rectal biopsy in
which PrPCWD could be detected in the culled
preclinical elk was 62% 6 27% (mean 6 SD; n 5 5
elk; Fig. 3, box plot), the variation from which was
minimal in biopsies having more than 10 follicles
available for examination.
The relationship between the number of RAMALT
follicles present within a biopsy section (follicles per
biopsy) and an elk’s age is shown in Figure 4 for the
first rectal biopsy sample obtained from 40 clinically
normal elk during the winter of 2005–2006 (the bull
with clinical signs of CWD was excluded from this
analysis). Under the field conditions of this study,
fewer follicles were present for evaluation within
rectal biopsies obtained from older elk; in fact, most
rectal biopsies from animals older than 5 years had
fewer than 10 RAMALT follicles present for evalu-
ation. The appearance of this inverse relationship of
follicles per biopsy with animal age was the same for
the results from biopsies obtained from the elk
remaining in the winter of 2006–2007 (data not
shown). Furthermore, there was no obvious differ-
ence between 132MM and 132LM genotypes (data
not shown).
Figure 3. The percent of follicles in which PrPCWD was
detected varied with the number of follicles present per rectal
biopsy in 5 cull-positive elk. Data shown are the antemortem
detection (.) or nondetection (#) of PrPCWD in rectal biopsies
obtained from cull-positive elk; all elk in this group were MM132
for the PRNP genotype at codon 132. Lines sequentially connect
biopsies obtained from the same animal, as indicated by the
sampling times (month-year.sample; sample indicates order if
more than 1 biopsy collected per time period). The vertical dashed
line offsets data outside of the interquartile range (gray horizontal
box) from those within the interquartile range, as determined by
the box-and-whisker plot of the first positive biopsy for 5 elk.
Figure 4. Relationship of the number of RAMALT follicles
observed per rectal biopsy to an animal’s age in a captive herd of
elk. Data are presented as the antemortem detection (closed
symbols) or nondetection (open symbols) of PrPCWD in the initial
rectal biopsy obtained from 15 cow elk (squares) and 25 bull elk
(circles) during the winter of 2005–2006. Note the inverse
relationship of follicle number per biopsy and animal age. Most
rectal biopsies obtained from animals younger than 5 years
contained at least 10 follicles (horizontal dashed line), whereas the
number of follicles per biopsy was fewer than 10 for most animals
older than 5 years.
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Postmortem RAMALT evaluation. A total of 3 to 6
full-thickness sections of rectum, starting at the
mucocutaneous junction and progressing anterior
for a distance of 10 cm, were prepared from tissue
collected at necropsy from 1 clinical case (Y167) and 2
preclinical cases (B162 and OR7L) in order to
compare the number of RAMALT follicles present
within a biopsy between sampling locations. The
number of RAMALT follicles observed within 1–
3 cm of the mucocutaneous junction ranged from 34–
67 per biopsy but were rarely present in samples more
than 3 cm anterior to the mucocutaneous junction.
Within the initial antemortem rectal biopsies from
these elk, 4, 15, and 45 RAMALT follicles per biopsy
were observed. The increased number of follicles in
these 3 antemortem biopsies probably represents
improved technique over the course of the project,
underscoring the impact of biopsy collection
technique (location, size, and depth) on the number
of RAMALT follicles likely to be present for
evaluation.
Additional observations of IHC immunolabeling in biopsies
of the rectal mucosa
In addition to the presence of IHC immunolabeling
within RAMALT follicles, bright red chromogen
deposits were also observed near the periphery of
neurons (Fig. 5A). A few small, bright red chromogen
deposits could be found in nonmyelinated nerves
(Fig. 5B). In addition, bright red chromogen deposits
could be found in the loose connective tissue of the
lamina propria near rectal mucosal cells (Fig. 5C).
Some or all of these immunolabeling patterns were
observed in the clinical elk and the 5 preclinical elk in
this study.
Discussion
Antemortem diagnosis of ovine scrapie is per-
formed by biopsy of lymphoid tissue from palatine
tonsil,13 nictitating membrane,12 and rectal mucosa.3,4
The disease-associated isoform of the ovine prion
protein is typically detectable in lymphoid tissue by
IHC immunolabeling at approximately one third to
one half of the incubation period, and thus is
Figure 5. A, photomicrograph of a small group of myenteric
neurons within the rectum of an elk with CWD. Note the positive
(P) bright red chromogen granules surrounding myenteric neurons
(N) located in a ganglion between bundles of smooth muscle (SM).
Immunohistochemical immunolabeling: streptavidin–alkaline
phosphatase method. Hematoxylin/bluing counterstain. Bar 5
50 mm. B, photomicrograph of the rectum of an elk with CWD.
Note the nonmyelinated nerve (N) containing an aggregate of
positive (P) bright red chromagen granules. The nerve is located
between smooth muscle bundles (SM) of the rectal wall.
r
Immunohistochemical immunolabeling: streptavidin–alkaline
phosphatase method. Hematoxylin/bluing counterstain. Bar 5
20 mm. C, photomicrograph of the rectum of an elk with CWD.
Note the positive (P) bright red chromogen granules within the
lamina propria (LP) and near rectal mucosal cells (MC).
Immunohistochemical immunolabeling: streptavidin–alkaline
phosphatase method. Hematoxylin/bluing counterstain. Bar 5
20 mm.
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considered a reasonable marker for preclinical scrapie
disease in sheep.24
Similarly, preclinical accumulation of PrPCWD in
palatine tonsil and retropharyngeal lymph node is
considered a reliable marker for preclinical CWD
disease in mule deer.12,13,20,22,23 Experimental oral
infection of mule deer resulted in PrPCWD accumula-
tion in alimentary tract–associated lymphoid tissues
(retropharyngeal lymph node, palatine tonsil, Peyer
patches of the small intestine, and mesenteric lymph
nodes) as early as 42 days after inoculation.19
The pathogenesis of CWD in elk is less well
defined. PrPCWD was detected in brain and lymph
nodes (68%), nodes only (19%), and brain only (13%)
in a sample of 226 naturally infected captive elk.20 If
PrPCWD accumulates in RAMALT follicles at a
frequency similar to that in the retropharyngeal
lymph node, the relatively high number of CWD-
infected elk with PrPCWD restricted to the central
nervous system will limit the sensitivity of RAMALT
testing as an antemortem test for CWD diagnosis in
preclinical animals. In the current study, biopsy-
negative animals culled for herd management reasons
were also negative by postmortem examination of
obex and retropharyngeal lymph node. The remain-
ing elk in this facility will be monitored by annual
RAMALT testing and complete necropsies when
culled. Larger studies of hunter-harvested elk and elk
removed from infected herds will be performed to
determine the sensitivity of RAMALT testing in elk.
The age of the animal might also affect the design of
diagnostic testing protocols. In this study, numerous
RAMALT follicles were present in the rectal biopsy
samples obtained antemortem from elk #5 years old,
but fewer follicles were present in biopsy samples
obtained from elk $6 years old. Thus, the number of
follicles present per biopsy sample appeared to decline
with age in this herd of elk and is similar to the findings
of a previous study on postmortem samples.21 Al-
though the minimum number of follicles necessary for
an accurate test is not known, the RAMALT follicle
number in this study was adequate for detection of
PrPCWD in 1 clinical elk and 5 preclinical elk between
4.5 and 6.5 years of age, which is the typical age of
ranch-raised elk with CWD.
The low numbers of follicles found occasionally in
young animals were believed to be attributable to the
experience of the person taking the biopsy samples.
Even though the biopsy technique is relatively easy,
there was a learning curve. For example, one problem
encountered initially was animal straining with
mechanical anal dilation. This caused protrusion of
the rectal mucosa, increasing the chance that the
biopsy would be collected further anterior to the
mucocutaneous junction than intended.
In this study, approximately 60% of the RAMALT
follicles were PrPCWD positive in biopsies containing
at least 10 follicles. The extent to which this
approximation depends on the epidemiology of this
particular outbreak is not known; CWD was ob-
served 5 years after introduction of elk from an
infected herd into this presumed naı̈ve herd, and
antemortem rectal biopsy sampling was performed 3
years after the first of the purchased animals
developed clinical disease. Herds with more recent
introduction of infected animals or long-term housing
of infected animals may have other characteristics.
Nonetheless, the proportions of positive RAMALT
follicles observed in the present antemortem study in
which at least 10 follicles per biopsy were present for
evaluation are quite similar to the proportions
previously reported for RAMALT samples collected
at necropsy from 2 other ranch-raised herds of elk.21
The interval between infection and the appearance
of PrPCWD in the RAMALT of elk is not known, but
disease progression appears to be highly variable and
can be rapid in some cases. In this herd, 1 animal was
diagnosed with CWD as early as 1.5 years, and 1
animal progressed from having no apparent clinical
signs of CWD but a positive rectal biopsy in January
2007 to having clinical disease and an obex IHC score
of 4 by July of that year. PrPCWD was not observed
within rectal biopsy samples from 2 of the 5 cull-
positive cases collected in the previous year, even
though 10 or more follicles were evaluated in those
samples. The observation that 2 of these animals had
obex IHC scores of 3 or 4 within a year after
converting to a positive rectal biopsy suggests that
involvement of the RAMALT occurs relatively late in
disease progression within elk, especially when
compared with scrapie in sheep.
No PRNP genotype is protective in experimental
disease,16 and CWD was diagnosed in wild elk of
genotype frequencies in proportion to their abun-
dance in the sampled population.17 However, PRNP
genotype was associated with a prolonged incubation
period in experimentally infected elk.7 If a lag time in
development of clinical signs is associated with a
delay in the onset of lymphoid tissue PrPCWD
accumulation in natural disease, PRNP genotype will
need to be considered when developing testing
protocols for Rocky Mountain elk.
In spite of the potential limitations, identification
of infected herds by whole-herd screening using
biopsy of the rectal mucosa should be a useful
adjunct to federal and state control programs. Rectal
biopsies can be performed in elk under restraint
conditions currently used for artificial insemination,
and the procedure can be done with disposable
instrumentation. This technique may prove to be
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useful in preventing movement of infected clinically
normal animals from herds of unknown CWD status if
they are tested prior to movement. Risk factors for
transmission of CWD in farmed herds in Canada
included exposure to elk that died of CWD or
developed clinical signs2; if identification and prompt
removal of elk earlier in disease reduce transmission
efficiency, rectal biopsies may be useful in management
of infected herds. It will be imperative for producers to
understand that a negative test cannot be interpreted
to mean that the elk is not infected; a biopsy-negative
elk may be in an early stage of infection with the CWD
agent before the detectable accumulation of PrPCWD in
RAMALT and other lymphoid tissues,21 or it may
represent one of the 13% of animals in which detection
of peripheral PrPCWD prior to accumulation in the
central nervous system is not possible.20
In addition to their value in regulatory programs,
antemortem tests using minimally invasive methods
have value in experimental studies of CWD patho-
genesis and transmission in elk. The distribution of
PrPCWD in the neural and extraneural tissues of
naturally infected elk at early stages of disease can
be examined in animals identified through live animal
testing. In this study, the finding of bright red
chromogen deposits indicative of PrPCWD on the
periphery of enteric neurons, nonmyelinated nerves
located within the intestinal submucosa, and loose
connective tissue of the lamina propria in the clinical
and preclinical elk examined in this study is extremely
interesting. The accumulation of PrPCWD on the
periphery of enteric neurons is similar to the
deposition observed around neurons of the central
nervous system, suggesting that PrPCWD also accu-
mulates in and around these peripheral neurons of the
intestinal tract early in disease. Similar findings have
been described in studies of the pathogenesis in sheep
and mule deer.1,4,8–11,18,19
Prospective studies on captive and free-ranging elk
using this technique are in progress. These studies will
delineate the diagnostic sensitivity and specificity of
RAMALT screening as a method for identification of
infected elk herds as part of an integrated manage-
ment program to reduce the incidence of CWD in
Rocky Mountain elk.
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